We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Regulatory Protein Modulates Transmembrane Signals

By Biotechdaily staff writers
Posted on 08 Jul 2002
A regulatory protein called NHERF2 (sodium/hydrogen exchanger regulatory factor 2), a member of the PDZ class of proteins, has been shown to mediate the cell's response to binding of parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP). More...
The study was reported in the June 20, 2002, issue of Nature.

PDZ domains were first identified as regions of sequence homology found in diverse signaling proteins. The name PDZ derives from the first three proteins in which these domains were identified: PSD-95 (a 95 kDa protein involved in signaling at the postsynaptic density), DLG (the Drosophila melanogaster Discs Large protein), and ZO-1 (the zonula occludens 1 protein involved in maintenance of epithelial polarity). PDZ domains function as protein-protein interaction modules. The first identified (and by far the most common) function of PDZ domains is the recognition of specific C-terminal motifs found in partner proteins, most often in the cytoplasmic tails of transmembrane receptors and channels.

Adenylyl cyclase activation is thought to be responsible for most cellular responses to PTH and PTHrP, although many actions appear to be independent of adenylyl cyclase. In the current study, researchers from Johns Hopkins University (Baltimore, MD, USA) and Harvard University (Boston, MA, USA) found that when NHERF2 is present along with the parathyroid hormone receptor, the signal is sent via calcium. If there is no NHERF2, then cAMP is responsible for delivering the message.

"The cell's decision to use calcium or cAMP is important because each generates different responses from its target proteins,” explained Dr. Mark Donowitz, professor of medicine at Johns Hopkins University and co-author of the study. "These results show that at the very earliest stage of cell signaling, called receptor binding, there is a switch that determines what kind of signal will be used. To understand cell signaling, you really have to know the whole system.”




Related Links:
Johns Hopkins University
Harvard University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Automatic CLIA Analyzer
Shine i6000
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.